tiprankstipranks
Trending News
More News >
Fujicopian Co., Ltd. (JP:7957)
:7957
Japanese Market

Fujicopian Co., Ltd. (7957) AI Stock Analysis

Compare
0 Followers

Top Page

JP:7957

Fujicopian Co., Ltd.

(7957)

Select Model
Select Model
Select Model
Neutral 50 (OpenAI - 5.2)
Rating:50Neutral
Price Target:
¥1,447.00
▼(-1.77% Downside)
Action:ReiteratedDate:02/18/26
The score is held back primarily by weak recent financial performance (2025 loss, revenue decline, and negative free cash flow), partially offset by a moderately levered balance sheet. Technical indicators and valuation are both broadly neutral, with a modest dividend yield but losses limiting P/E-based support.
Positive Factors
Recurring consumables revenue
A consumables-focused business generates repeat purchasing tied to customers' printing volumes, creating durable baseline demand. This recurring revenue profile supports predictability of sales, aftermarket customer relationships, and potential steady cash inflows independent of one-off hardware cycles.
Moderate leverage on balance sheet
Relatively low debt-to-equity gives the company financial flexibility to manage cyclical pressure and invest selectively without excessive refinancing risk. Over a 2–6 month horizon this moderate leverage reduces insolvency risk and supports working-capital management during recovery phases.
Proven ability to deliver margins in prior cycles
Historical profitability demonstrates the business model and operations can produce healthy margins when volumes or pricing recover. That operational capacity implies management can restore earnings via cost control, pricing or mix improvements, making a return to profitability feasible within months.
Negative Factors
Sharp 2025 loss and revenue decline
A large recent loss and shrinking topline indicate structural demand or pricing weakness and margin pressure. This reduces internal funding for investments and raises execution risk; restoring revenue and margins is necessary for durable recovery and remains a material short-term fundamental challenge.
Persistently negative free cash flow
Sustained negative free cash flow limits the firm's ability to self-fund capex, inventory, or working capital needs, increasing dependence on external financing. Weak cash conversion undermines flexibility and heightens refinancing and liquidity risk over a 2–6 month horizon if losses persist.
Material decline in equity cushion
A reduced equity base shrinks the company's shock-absorbing capacity and effectively increases leverage ratios, making credit access and covenant headroom tighter. Continued erosion could constrain strategic choices and supplier/customer confidence in the near term.

Fujicopian Co., Ltd. (7957) vs. iShares MSCI Japan ETF (EWJ)

Fujicopian Co., Ltd. Business Overview & Revenue Model

Company DescriptionFujicopian Co., Ltd. manufactures and sells consumable supplies for information and data processing applications in Japan and internationally. The company's products include FIXFILM; and thermal transfer media products, such as thermal color and monochrome ribbons that are used in home fax machines, barcode printers, and various types of ticket dispensing machines. It also provides stationary products comprising correction and glue tapes; fabric ribbons for use in printers and typewriters; correctable film ribbons; and multi-strike film ribbons, as well as analysis and measurement services. The company was incorporated in 1950 and is headquartered in Osaka, Japan.
How the Company Makes MoneyFujicopian generates revenue through the sales of its specialty printing supplies, which include a range of inks, coatings, and adhesives. The company has established key partnerships with major players in the packaging and printing industries, enabling it to secure long-term contracts and bulk orders. Additionally, Fujicopian benefits from a diversified customer base, spanning both domestic and international markets, which helps mitigate risks associated with fluctuations in demand. The company also invests in research and development to innovate and improve its product offerings, thereby enhancing its competitive edge and potentially increasing sales and profitability.

Fujicopian Co., Ltd. Financial Statement Overview

Summary
Overall financials are pressured: the income statement reflects a sharp swing to a large net loss in 2025 with declining revenue and margin compression, and cash flow quality is weak with persistently negative free cash flow in 2022–2025. The balance sheet is a relative strength with moderate leverage, but equity declined materially in 2025, reducing the cushion.
Income Statement
34
Negative
Profitability and growth have been volatile. Revenue declined in 2025 (annual) after modest growth in 2024, and margins compressed versus prior years (gross margin ~21% in 2025 vs ~23% in 2024). Earnings swung sharply to a large net loss in 2025 after a profit in 2024, with operating profit also negative in 2025. Strengths include a prior ability to generate positive margins in 2021–2022 and a meaningful EBITDA margin in 2024, but the recent swing to losses and declining revenue weighs heavily on the score.
Balance Sheet
66
Positive
Leverage appears moderate and generally controlled, with debt-to-equity around ~0.24–0.34 across the period, which is supportive for a cyclical/volatile earnings profile. However, equity declined materially in 2025 versus 2024, consistent with the large loss, reducing the balance-sheet cushion. Overall, the company looks not overly levered, but the recent hit to equity and profitability increases risk if weak operating conditions persist.
Cash Flow
29
Negative
Cash generation has weakened and free cash flow has been persistently negative in recent years. Operating cash flow turned only modestly positive in 2025 (annual) and was negative in 2023, while free cash flow remained negative in 2022–2025 (and improved only sporadically). A key concern is that operating cash flow has been small relative to reported earnings in loss/profit years, indicating weaker cash conversion and/or working-capital or investment pressure. The main positive is that operating cash flow was solid in 2020–2022, but the recent trend is unfavorable.
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue8.98B8.48B8.98B8.23B9.85B8.60B
Gross Profit2.17B1.80B2.11B1.36B2.67B2.29B
EBITDA1.14B436.46M1.13B-116.50M1.22B976.03M
Net Income419.18M-2.70B397.76M-856.27M490.48M369.65M
Balance Sheet
Total Assets16.23B13.87B16.44B16.16B17.82B16.22B
Cash, Cash Equivalents and Short-Term Investments3.29B2.54B2.86B3.23B4.27B4.33B
Total Debt3.17B2.72B2.52B2.82B3.02B2.77B
Total Liabilities5.94B5.90B5.88B5.82B6.69B5.74B
Stockholders Equity10.29B7.97B10.57B10.34B11.14B10.48B
Cash Flow
Free Cash Flow0.00-457.60M-290.00M-880.88M-280.75M208.34M
Operating Cash Flow0.00101.91M299.61M-46.68M706.53M898.64M
Investing Cash Flow0.00-532.99M-248.67M-778.71M-988.16M-728.27M
Financing Cash Flow0.0059.60M-422.06M-267.47M40.97M-451.11M

Fujicopian Co., Ltd. Technical Analysis

Technical Analysis Sentiment
Positive
Last Price1473.00
Price Trends
50DMA
1450.39
Positive
100DMA
1443.52
Positive
200DMA
1432.40
Positive
Market Momentum
MACD
3.04
Negative
RSI
65.62
Neutral
STOCH
51.95
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7957, the sentiment is Positive. The current price of 1473 is above the 20-day moving average (MA) of 1454.75, above the 50-day MA of 1450.39, and above the 200-day MA of 1432.40, indicating a bullish trend. The MACD of 3.04 indicates Negative momentum. The RSI at 65.62 is Neutral, neither overbought nor oversold. The STOCH value of 51.95 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:7957.

Fujicopian Co., Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (63)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
71
Outperform
¥184.00B15.392.56%-0.26%3.35%
71
Outperform
¥123.03B21.462.09%6.39%-34.84%
70
Neutral
¥4.19B20.152.03%3.24%
63
Neutral
$10.79B15.437.44%2.01%2.89%-14.66%
58
Neutral
¥23.49B43.981.69%-2.71%
50
Neutral
¥2.27B-0.845.27%0.34%
42
Neutral
¥3.41B-15.384.11%33.06%
* Industrials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:7957
Fujicopian Co., Ltd.
1,481.00
47.29
3.30%
JP:7846
Pilot Corporation
4,775.00
684.90
16.75%
JP:7962
King Jim Co., Ltd.
825.00
-9.29
-1.11%
JP:7975
LIHIT LAB., INC.
1,234.00
134.79
12.26%
JP:7976
Mitsubishi Pencil Company, Limited
2,375.00
-110.19
-4.43%
JP:7992
Sailor Pen Co., Ltd.
115.00
15.00
15.00%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Feb 18, 2026